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Abstract: Alcohol and cannabis use are highly prevalent among adolescents and associated with
negative consequences. Understanding motivations behind substance use in youth is important
for informing prevention and intervention efforts. The present study aims to examine negative
reinforcement principles of substance use among adolescent cannabis and alcohol users by pairing a
cue reactivity paradigm with an aversive interoceptive stimulus. Adolescents (ages 15–17), classified as
controls (CTL; n = 18), cannabis and/or alcohol experimenters (CAN+ALC-EXP; n = 16), or individuals
meeting clinical criteria for cannabis and/or alcohol use disorder (CAN+ALC-SUD; n = 13) underwent
functional magnetic resonance imaging during which they experienced an aversive interoceptive
probe delivered via breathing load while simultaneously performing a cue reactivity paradigm.
Participants also provided self-report ratings of how their substance use is positively or negatively
reinforced. While experiencing the breathing load, CAN+ALC-SUD exhibited greater (p < 0.05)
deactivation in the right amygdala, the left inferior frontal gyrus, and the left parahippocampal gyrus
than CAN+ALC-EXP and CTL, who did not differ. Across all substance users, activation during
the breathing load within the left parahippocampal gyrus negatively correlated with cannabis and
alcohol lifetime use episodes and the left inferior frontal gyrus activity negatively correlated with
lifetime alcohol use episodes. CAN+ALC-SUD reported experiencing more positive and negative
reinforcement of using their substance of choice than CAN+ALC-EXP; both user groups reported
higher levels of positive than negative reinforcement. Adolescents with a cannabis/alcohol use disorder
demonstrate an altered response to interoceptive perturbations. However, adolescent cannabis/alcohol
use does not appear to be driven by negative reinforcement, as viewing substance images did not
dampen this response. Based on self-report data, the experience of positive reinforcement may be
stronger for adolescents. Future studies should examine whether positive reinforcement contributes
to adolescent substance use.
Keywords: cannabis; alcohol; adolescents; fMRI; interoception; negative reinforcement; cue reactivity
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1. Introduction
Increased risk-taking behavior is characteristic of adolescence, a critical time period marked by
significant physical, cognitive, and behavioral development [1]. A common risky behavior initiated in
adolescence is the use of illicit substances. Among 12th graders, approximately 44% report having
used cannabis and approximately 59% report having used alcohol in their lifetime [2]. Adolescent
substance use can also evolve into a substance use disorder (SUD). For example, in 2018, 2.1% of
adolescents aged 12–17 met criteria for cannabis use disorder, while 1.6% met criteria for alcohol use
disorder [3]. Substance use during adolescence also increases future risk of experiencing adverse
consequences related to use; early adolescent cannabis use may contribute to low educational or
occupational attainment, as well as increased use and development of a use disorder in adulthood [4].
Similarly, youth who initiate drinking before age 15 are at increased risk of developing an alcohol use
disorder within their lifetime compared to youth who remain abstinent until age 21 [5,6]. Given the
increased risks associated with adolescent substance use, it is important to improve our understanding
of the motivations behind these behaviors in order to inform SUD prevention and intervention efforts.
Altered interoceptive-related neural processing has been implicated in SUD in combination with
emotion dysregulation and decision-making deficits, resulting in suboptimal behavioral adjustments
and the propensity to continue drug use despite negative consequences [7–12]. To date, examination of
the brain mechanisms involved in interoception and negative reinforcement has focused on adult SUD
and little research has examined these concepts among adolescent substance users [13–15].
Interoception is a biological and psychological process by which somatosensory information
from inside and outside of the body is filtered and integrated within the brain to produce an overall
representation of the bodily state [16]. Anterior cingulate cortex (ACC), thalamus, frontal regions,
and insular cortex (IC) are components of brain circuitry essential for processing and integrating bodily
afferents to generate an overall representation of the body [16–18]. Afferent signals pass through
thalamocortical pathways to IC to be integrated with sensorimotor activity and emotional information
delivered by ACC and frontal regions such as inferior frontal gyrus (IFG) [16]. This process results in
complex interoceptive feeling states or emotional awareness [18] and may lead to a bodily prediction
error if the experienced state differs from the expected state [19–22]. Body prediction errors motivate
individuals to engage in goal-directed behavior (e.g., substance use) and either approach or avoid
stimuli (e.g., substance-related stimuli) with the aim of reestablishing equilibrium [23].
Among non-substance-using individuals, frontocingulate regions, including IFG and ACC, are
thought to act as a regulatory system of behavioral reactions in response to aversive stimuli [24,25].
However, among individuals with SUD this regulatory system appears altered. For example, IFG and
ACC blood oxygen-level dependent (BOLD) signal reductions in response to negative interoceptive
stimuli have been found to characterize young adults transitioning to stimulant use disorders [8,26]
while adolescent substance users have also demonstrated an increased IFG BOLD signal in response to
a negative interoceptive stimuli [27]. In general, differing patterns of ACC, IFG, and IC activation have
distinguished substance users from healthy individuals [28]. These frontocingulate deficits may be
linked to reduced motivation to engage in behavioral changes to reestablish equilibrium despite feeling
or sensing consequences of aversive bodily stimulation [29]. In addition to interoceptive processing,
poor emotion regulation, an inability to effectively reduce arousal and cope with negative emotions
has been implicated in adolescent substance use and requires similar brain regions [30]. The IFG and
amygdala comprise a brain circuit involved in determining the emotional significance of an external
stimulus and signaling the physiological, behavioral, cognitive, and affective responses necessary to
minimize the impact of unpleasant stimuli [25,30–33].
One conceptualization of SUD, based on negative reinforcement principles, posits that individuals
use drugs in order to alleviate uncomfortable feelings in general (e.g., emotional dysregulation,
uncomfortable interoceptive states) [34,35]. For example, dysfunctional interoceptive processing
may result in substance users seeking out and consuming drugs in order to reduce uncomfortable
interoceptive states. Neuroimaging research suggests that drug cues activate brain regions similar to
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those activated by aversive interoceptive stimuli; cannabis cues elicit activation in parahippocampal gyri
and various frontal regions among non-treatment-seeking cannabis-using adolescents [36]. Adolescents
who primarily use alcohol also demonstrate an exaggerated neural response within frontal regions
including IFG, parahippocampus, amygdala, and posterior cingulate in response to cue images [37].
Accordingly, the present study pairs an aversive interoceptive stimulus with a cannabis and alcohol
cue reactivity task during functional magnetic resonance imaging. This pairing is viewed as a proxy
for negative reinforcement, allowing for the examination of whether the rewarding effects of substance
images dampen the negative experience of the breathing load. Specifically, we posit that viewing
rewarding drug-relevant cues will dampen the interoceptive BOLD response observed in adolescent
substance users while experiencing an aversive interoceptive stimulus.
An inspiratory breathing load can be used as an aversive stimulus to induce a negative interoceptive
state [38] and has previously been tested among young adult [8,39], adult [40], and adolescent substance
users [27] as well as matched controls. While experiencing the breathing load, young adults with
problem stimulant use show lower IFG, IC, and ACC activation compared to individuals who no
longer use stimulants as well as non-using controls [8,39]. Similarly, adults with a significant history of
methamphetamine use currently meeting criteria for a methamphetamine use disorder also show lower
IC and ACC during the breathing load [40]. Despite these differences in brain activation, groups did
not differ in their subjective ratings of the breathing load experience. Overall, the reduced activation
seen in regions implicated in interoceptive processing is conceptualized as an overall diminished ability
to regulate when one does not feel well, and that this inability contributes to continued substance use
despite negative consequences. To date, only one study has utilized an inspiratory breathing load with
adolescent substance users; these results revealed an overactivation in interoceptive regions. This
inconsistent finding suggests that alterations in interoceptive processing may differ as a function of
age, type of substance used, or amount of substance used.
The current study is the first to pair an aversive interoceptive stimulus with a cue reactivity
paradigm to examine the role of negative reinforcement in substance use. In addition, the sample of the
present study includes adolescents (ages 15–17) who report cannabis and alcohol use with and without
use disorders. This will allow for the examination of negative reinforcement and interoceptive-related
neural responses within diagnostically subthreshold adolescent substance users to investigate whether
altered processing is simply a consequence of use or unique to adolescents experiencing functional
impairments related to use (i.e., adolescents with use disorder diagnoses).
Participants included adolescents meeting criteria for either cannabis and/or alcohol use disorder,
adolescents who use cannabis and alcohol but do not meet diagnostic criteria (experimenters) and
healthy comparison participants. On the basis of prior work, it was hypothesized that substance
users meeting diagnostic criteria compared to controls would show: (1) increased neural activation
in response to the breathing load across all conditions of the cue task in brain regions involved in
interoceptive processing, such as IC, ACC, and IFG, as well as regions implicated in emotion regulation,
including amygdala and parahippocampal gyrus [27]; (2) increased striatal response while viewing
substance images across all breathing load conditions, reflecting heightened reward responsivity to
substance cues [41,42]; and (3) a blunted interoceptive neural response to the breathing load when
paired with substance images (cannabis and alcohol images) suggesting exposure to a conditioned drug
stimulus may help modulate reactions to internal and aversive states similar to negative reinforcement
principals of drug use behavior. Additionally, adolescent substance users who did not meet criteria for
SUD, referred to as “experimenters”, were included to explore whether neural differences are more
pronounced in adolescent substance users who endorse substance use-related functional impairment
(i.e., adolescents meeting criteria for SUD) than those who do not. Therefore, it was hypothesized
that experimenters would demonstrate a neural response more similar to controls than those meeting
substance use disorder criteria, suggesting that impaired brain responses are a consequence of more
severe use symptomatology.
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2. Materials and Methods
2.1. Participants
Adolescent participants (n = 47, ages 15–17) were recruited through local high schools by flyers
that advertised an adolescent neuroimaging research study consisting of a clinical interview and
neuroimaging session. The University of California San Diego Human Research Protections Program
approved the study protocol. Adolescent participants provided assent and informed consent was
obtained from one parent or legal guardian prior to study enrollment. Participants were excluded
if they endorsed any of the following: (1) lifetime Diagnostic and Statistical Manual (DSM-5) of
Mental Disorders psychiatric disorder (other than substance use disorder, SUD); (2) current use of
psychoactive medications; (3) history of major neurological or medical disorder; (4) head injuries or
loss of consciousness > 5 min; (5) irremovable metal in body; (6) pregnancy; (7) non-correctable vision
or hearing problems; (8) premature birth or prenatal alcohol/drug exposure; (9) left handedness; or (10)
claustrophobia. Eligible participants received financial compensation for their participation.
The final sample consisted of 18 controls with very minimal histories of substance use (CTL;
cannabis/alcohol maximum lifetime use episodes of 3 each, nicotine maximum lifetime use episodes
of 10; 13M, 5F), 16 cannabis and alcohol experimenters (CAN+ALC-EXP; 12M, 4F), and 13 who met
criteria for cannabis and/or alcohol use disorder (CAN+ALC-SUD; 9M, 4F). SUD group classification
required a report of cannabis or alcohol use within the past three months, current endorsement of 2
or more DSM-5 SUD criteria for either cannabis or alcohol, and fewer than 15 lifetime uses of other
drugs except for nicotine (see Table 1 for diagnostic details). On average, CAN+ALC-SUD participants
reported 467 lifetime cannabis uses and 131 lifetime alcohol uses. CAN+ALC-EXP group classification
required a report of no substance use history other than alcohol, cannabis, or nicotine, and no current
or lifetime endorsement of DSM-5 SUD criteria. CAN+ALC-EXP reported significantly less cannabis
(t(12.48) = −5.31, p < 0.001) and alcohol use (t(12.28) = −3.12, p < 0.009) than SUD but significantly
more use of these substances than CTL (cannabis: t(15) = −3.46, p = 0.003; alcohol: t(15.06) = −4.29,
p = 0.001) (see Table 1).
2.2. Clinical Interview
The clinical interview consisted of the Semi-Structured Assessment for Drug Dependence and
Alcoholism (SSADDA; [43]) to assess for the presence of SUD and the Customary Drinking and Drug
Use Record (CDDR) [44] to capture quantity of lifetime substance use, age of first use, and last substance
use. Participants provided demographic information and a battery of self-report measures to assess
characteristics related to SUD including the UPPS Impulsive Behavior Scale [45], the Multi-Dimensional
Assessment of Interoceptive Awareness (MAIA) [46], and the Michigan Nicotine Reinforcement
Questionnaire (MNRQ) [47]. The MNRQ was modified to assess negative reinforcement principles
related to users’ substance of choice rather than nicotine. Each participant was asked to indicate their
drug of choice (cannabis, alcohol) and answer the MNRQ questions regarding their experiences with
that drug rather than nicotine. The specific questions and scale were not altered.
2.3. Neuroimaging Procedures
Participants were asked to abstain from substance use for at least 72 h prior to their fMRI session
as confirmed by combination of self-report, breathalyzer, and urine toxicology screens. A positive
result for any substance other than cannabis excluded individuals from the study. Acute cannabis use
is difficult to determine by examination of urinary metabolites and therefore use within the past 72 h
is possible; however, all participants self-reported abstaining for the 72 h prior to the appointment
and only 5 (4 CAN+ALC-SUD, 1 CAN+ALC-EXP) participants were positive for THC on the day of
testing, which could reflect use from up to four weeks prior given the regularity of their use history.
The Cue Breathing fMRI paradigm paired a cue reactivity task with anticipation and experience of
an unpleasant interoceptive stimulus, an inspiratory breathing load. Each participant received either
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a cannabis or alcohol version of the task, depending on their reported primary substance of choice.
For the cue reactivity task, participants were presented with images of substances (cannabis or alcohol),
comparison images consisting of closely matched objects resembling the substance images (e.g.,
dried leaves resembling cannabis, non-alcoholic beverages), or scrambled versions of the substance
and comparison images where the object in the image was unidentifiable. CTL viewed the same
version of the task (cannabis or alcohol) as an age-matched substance-using participant. While viewing
each image, participants were asked to indicate whether they disliked, felt neutral, or liked the image.
Participants provided ratings using the first three buttons of a four-button box and saw a red box
appear on screen to confirm their selected answer.
Table 1. Characteristics of Substance Use.
CAN+ALC-SUDGroup
Description
% Meeting Diagnostic Criteria Diagnostic Criteria Endorsed
M(SD) Min Max
THC Use Disorder 92.31 3.42 (1.38) 2 6
Alcohol Use Disorder 61.54 2.63 (.74) 2 4
Substance Use
CAN+ALC-SUD
Cannabis/Alcohol
Substance Use
Disorder
CAN+ALC-EXP
Cannabis/Alcohol
Experimenter
CTL
Little to No
Substance Use
df t p
Lifetime Cannabis Use 467.85 (288.05) 39.38 (45.15) 0.17 (0.514) 12.48 −5.31 <0.001
Days Since Last THC Use 18.69 (33.34) 71.69 (82.25) 46.11 (160.19) 20.63 2.35 0.029
Lifetime Alcohol Use 131.92 (131.55) 17.44 (15.87) 0.22 (0.73) 12.28 −3.12 0.009
Days Since Last Alcohol 16.46 (11.67) 45.38 (98.99) 22.22 (66.12) 27 1.04 0.306
Lifetime Alcohol Binge Episode 92.83 (71.90) 7.87 (7.97) 0.11 (0.47) 11.22 −4.07 0.002
Days Since Last Binge 24.70 (24.83) 90.93 (135. 77) 240 (–) 15.38 1.84 0.085
Lifetime Hallucinogen Use 2.69 (3.88) 0.13 (0.50) – 12.32 −2.37 0.035
Days Since Last Hallucinogen 82.31 (93.58) 9.81 (39.25) – 15.42 −2.61 0.019
Lifetime Sedative Use 0.77 (1.36) – – 12.00 −2.03 0.065
Days Since Last Sedative Use 179.15 (330.97) – – 12.00 −1.95 0.075
Lifetime Amphetamine Use 0.31 (1.11) – – 12.00 −1.00 0.337
Days Since Last Amphetamine Use 14.46 (52.14) – – 12 −1.00 0.337
Lifetime Rx Stimulant Use 1.92 (5.48) 0.06 (0.25) – 12.04 −1.22 0.245
Days Since Last Rx Stimulant Use 148.23 (297.47) 17.94 (71.75) – 13.14 −1.54 0.147
Lifetime Cocaine Use 0.92 (1.50) – – 12.00 −2.22 0.046
Days Since Last Cocaine Use 55.00 (91.33) – – 12.00 −2.17 0.051
Lifetime Ecstasy Use 14.85 (27.65) – – 12.00 −1.94 0.077
Days Since Last Ecstasy Use 293.62 (333.72) – – 12.00 −3.17 0.008
Lifetime Opiate Use 0.92 (2.75) 1.94 (7.49) – 27 0.462 0.647
Days Since Last Opiate Use 139.31 (277.92) 26.56 (73.13) – 13.35 −1.42 0.178
Lifetime Inhalant Use 2.38 (8.30) – – 12.00 −1.04 0.321
Days Since Last Inhalant Use 106.00 (259.42) – – 12.00 −1.47 0.166
Lifetime Nicotine Use 232.00 (409.19) 4.19 (6.73) 0.56 (2.36) 12.00 −2.01 0.068
Days Since Last Nicotine Use 92.69 (108.66) 130.69 (157.63) 21.94 (93.10) 26.39 0.766 0.451
Participants wore a nose clip and respired through a mouthpiece with a non-rebreathing valve
(2600 series, Hans Rudolph). The breathing equipment was attached to the scanner head coil using
Velcro straps to help hold the mouthpiece in position and eliminate the need for participants to contract
their mouth muscles. The mouthpiece connected to a hose that allowed for an inspiratory resistance
load of 40 cmH2O/L/s to be attached. This breathing load consisted of a Plexiglas tube with a sintered
bronze disk inside that partially limited airflow thereby producing a resistance load. A breathing load
of 40 cm H2O/L/s was selected based on previous research which has demonstrated that this load alters
subjective symptoms without significantly affecting CO2 or O2 levels, and thereby does not impact
the BOLD signal [48,49]. Prior to the scan, participants completed a training session during which
they were introduced to the breathing equipment and practiced the task. Individuals experienced
increasing levels of restriction up to the target load of 40 cm H2O/L/s. The breathing load was described
as feeling like “you are breathing through a straw” and participants were instructed to continue to
breathe normally while experiencing the restriction. While in the scanner, participants experienced the
breathing load at various times throughout the task for approximately 40 s at a time. Each block of
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images began with one null trial that lasted for 6 s. During this time, participants saw either a yellow
or grey fixation screen. Yellow indicated there was a 1 in 4 (25%) chance of experiencing the breathing
load during the next block of images. Alternatively, a grey fixation screen indicated there would be no
chance of experiencing the breathing restriction during the upcoming block of images. Each null trial
was followed by 6 pictures of the same type (substance, neutral, or scrambled) presented one at a time
for 4 s each.
There was a total of 9 task conditions: anticipation neutral images, anticipation substance images,
anticipation scrambled images, breathing load neutral images, breathing load substance images,
breathing load scrambled images, neutral images only, substance images only, and scrambled images
only. Trials during which neutral or scrambled images were presented without the anticipation or
experience of the breathing load were combined into a baseline condition. This resulted in 5 conditions
of interest: (1) baseline: neutral and scrambled images with no anticipation or breathing restriction; (2)
anticipation neutral images: blocks of neutral images preceded by a yellow fixation screen during which
the participant did not actually experience the breathing load; (3) anticipation substance images: blocks
of substance images preceded by a yellow fixation screen during which the participant did not actually
experience the breathing load; (4) breathing load neutral images: blocks of neutral images preceded by a
yellow fixation screen during which the participant did experience the breathing load; (5) breathing load
substance images: blocks of substance images preceded by a yellow fixation screen during which the
participant did experience the breathing load (see Figure 1).Brain Sci. 2020, 10, x FOR PEER REVIEW 8 of 19 
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with the breathing load using a Visual Analog Scale (VAS). Participants rated the breathing load for
pleasantness, unpleasantness, and intensity using a 10 cm scale ranging from ‘not at all’ to ‘extremely’.
After the scan, participants used the same VAS to rate their in-scanner experience of the breathing load.
2.4. Neuroimaging Data Acquisition
The cue reactivity paradigm was presented during one fMRI scan sensitive to blood oxygenation
level-dependent (BOLD) contrast using a Signa EXCITE (GE Healthcare, Chicago, IL, USA) 3.0 Tesla
scanner (T2*-weighted echo planar imaging (EPI) scans, TR = 2000 ms, TE = 30 ms, FOV = 24 cm
(squared), 64× 64× 40 matrix, forty 3.0 mm axial slices with an in-plane resolution of 3.75 × 3.75 × 3 mm,
flip angle = 90 degrees, 420 whole-brain acquisitions). For anatomical reference, a high-resolution
T1-weighted image (spoiled gradient recalled [SPGR], TR = 8 ms, TE = 3 ms, slices = 172, FOV = 25 cm
approximately 1 mm3 voxels) was obtained.
2.5. Neuroimaging Data Analysis
2.5.1. Individual-Level Processing
All neuroimaging data was processed using the Analysis of Functional NeuroImages (AFNI)
software package [50]. Following data acquisition, GE slices were reconstructed into AFNI BRIK format.
Baseline volume for 3D registration was constructed using the largest temporal region containing the
fewest voxel-wise outliers. Data was aligned to the baseline image using all other time points in dx,
dy, dz, and roll, pitch, and yaw directions. The functional EPI underwent automatic coregistration to
the high-resolution anatomical image and each alignment was manually inspected for each dataset.
New outliers were generated for the volume-registered dataset based on whether a given time point
greatly exceeded the mean number of voxel outliers for the time series. Six motion regressors (dx, dy, dz
and roll, pitch, and yaw), a baseline and linear drift regressor, and nine task-related regressors (trials for
anticipation neutral images, anticipation substance images, anticipation scrambled images, breathing
load neutral images, breathing load substance images, breathing load scrambled images, neutral
images only, substance images only, and scrambled images only) were convolved with a modified
hemodynamic response function. The baseline condition, during which there was no cue or experience
of the breathing load, served as the baseline for this analysis. A Gaussian Spatial Filter (6 mm full
width-half maximum) was used to spatially blur data to account for anatomical differences. Automated
transformations were applied to anatomical images and EPIs were subsequently transformed into
Montreal neurological institute (MNI) space. Percent signal change (PSC) was determined by dividing
each regressor of interest (anticipation neutral images, anticipation substance images, breathing load
neutral images, breathing load substance images) by the baseline regressor and multiplying by 100.
2.5.2. Group-Level Analysis
A linear mixed-effects (LME) analysis (r-project.org) was performed to examine group differences
in brain activation. Participants were treated as random effects, while group (CAN+ALC-SUD,
CAN+ALC-EXP, CTL), interoceptive condition (no breathing load [anticipation], breathing load),
and image type (neutral, substance) were treated as fixed effects. PSC from baseline (trials consisting of
neutral and scrambled images and no chance or experience of the breathing load) was the dependent
variable. The group main effect was examined to identify differences between CAN+ALC-SUD,
CAN+ALC-EXP, and CTL across breathing load and cue image type conditions. The group by
image type interaction was conducted to examine group differences while viewing substance images
across all interoceptive conditions. The group by interoceptive condition interaction was examined
to test hypotheses involving anticipation and receipt of the aversive interoceptive breathing load
in CAN+ALC-SUD and CTL. The group by interoception by image type interaction was of interest
because it allowed for examination of whether substance users show a blunted response to the aversive
interoceptive stimuli when paired with the rewarding substance images. To guard against identifying
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false-positive areas of activation, a threshold adjustment method was applied using AFNI programs
3dFWHMx and 3dClustSim with the auto-correlation function (acf). The 3dClustSim identified a
minimum cluster volume of 1280 µL (20 contiguous voxels) corresponding to a per-voxel p-value of
0.002 (bi-sided, NN = 3) to result in a voxel-wise probability of p < 0.05 (two-sided) corrected for
multiple comparisons.
3. Results
3.1. Subject Characteristics
Groups did not differ in terms of demographics, including age (F(2, 44) = 1.27, p = 0.290), education
(F(2,43) = 0.956, p = 0.392), racial (χ2(8) = 9.043, p = 0.339) and ethnic (χ2(2) = 0.10, p = 0.953) makeup,
and gender distribution (χ2(2) = 0.37, p = 0.830); each group had more males than females. Moreover,
there was no difference in subjective self-reported unpleasantness (F(2,44) = 0.432, p = 0.652) or
intensity (F(2,44) = 2.68, p = 0.08) of the breathing load and the groups did not differ on self-reported
interoceptive awareness and impulsivity. However, CAN+ALC-SUD compared to CAN+ALC-EXP
reported higher levels of positive and negative reinforcement on the MNRQ. Additionally, both user
groups reported higher levels of positive reinforcement than negative reinforcement on the MNRQ
(see Table 2).
Table 2. Sample Characteristics.
CAN+ALC-SUD
Cannabis/Alcohol
Substance Use Disorder
CAN+ALC-EXP
Cannabis/Alcohol
Experimenter
CTL
Little to No
Substance Use
Demographics M(SD) M(SD) M(SD) df F p
Age (in years) 16.62 (0.51) 16.69 (0.70) 16.33 (0.77) 2,44 1.27 0.290
Education (in years) 10.46 (0.78) 10.47 (0.83) 10.11 (0.90) 2,43 0.956 0.392
WRAT 4 Verbal IQ 107.31 (14.29) 106.75 (12.37) 112.00 (13.82) 2,44 0.770 0.469
VAS Ratings M(SD) M(SD) M(SD) df F p
Unpleasant 5.69 (3.29) 4.63 (2.64) 5.34 (3.49) 2,44 0.432 0.652
Intensity 4.08 (3.47) 2.13 (2.77) 4.41 (2.89) 2,44 2.68 0.08
Questionnaires M(SD) M(SD) M(SD) df F/t p
MAIA
Noticing 2.83 (1.52) 2.75 (1.03) 2.78 (1.19) 2,43 0.016 0.984
Not Distracting 2.14 (0.50) 2.37 (1.12) 2.52 (1.30) 2,43 0.443 0.645
Not Worrying 2.89 (1.43) 2.81 (1.42) 2.70 (1.05) 2,43 0.079 0.925
Attention Regulation 3.17 (.95) 3.45 (0.74) 3.14 (1.15) 2,43 0.494 0.613
Emotional Awareness 3.18 (1.43) 3.04 (1.31) 3.07 (.93) 2,43 0.054 0.948
Self-Regulation 3.10 (1.05) 3.23 (0.90) 3.01 (1.05) 2,43 0.207 0.814
Body Listening 1.36 (1.16) 1.96 (1.44) 1.79 (1.05) 2,43 0.844 0.437
Trusting 3.47 (1.40) 3.73 (1.08) 3.72 (0.92) 2,43 0.231 0.795
UPPS
Lack of Premeditation 2.08 (0.39) 2.18 (0.49) 1.89 (0.42) 2,44 1.92 0.159
Urgency 2.30 (0.66) 2.17 (0.59) 2.06 (0.51) 2,44 0.672 0.516
Sensation Seeking 3.18 (0.29) 3.09 (0.48) 3.03 (0.44) 2,44 0.528 0.594
Lack of Perseverance 2.03 (0.59) 2.13 (0.58) 1.83 (0.34) 2,44 1.53 0.229
MNRQ
Negative Reinforcement 2.85 (2.38) 0.875 (1.63) – 20.52 2.55 0.019
Positive Reinforcement 11.38 (2.53) 7.25 (3.45) – 27 3.59 0.001
3.2. Neuroimaging Results
No clusters met the thresholding requirement of 20 voxels for the main effect of group, the group by
image type interaction, or the three-way group by interoceptive condition by cue image type interaction.
3.2.1. The Group by interoception interaction
Four brain regions survived thresholding: the right amygdala, the left IFG, the right posterior
cingulate, and the left parahippocampal gyrus. (see Table 3). All interactions remained significant after
controlling for lifetime nicotine use.
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Table 3. fMRI results and between-group comparisons (SUD = CAN+ALC-SUD;
EXP = CAN+ALC-EXP).
GROUP BY INTEROCEPTIVE CONDITION INTERACTION
R/L Voxels Volume X Y Z BA Anticipation Load
Amygdala R 33 2112 28 −9 −30 28 SUD > EXP EXP > SUD
Inferior Frontal Gyrus L 28 1792 −13 24 −20 11 – EXP = CTL > SUD
Posterior Cingulate R 25 1600 13 −65 16 31 – EXP = SUD > CTL
Parahippocampal Gyrus L 21 1344 −24 −7 −19 35 CTL > EXP CTL = EXP > SUD
MAIN EFFECT OF INTEROCEPTIVE CONDITION
R/L Voxels Volume X Y Z BA Condition Effect
Cingulate Gyrus R 3141 201024 8 −6 23 24 Load > Anticipation
Fusiform Gyrus R 663 42432 40 −12 −24 20 Anticipation > Load
Superior Frontal Gyrus R 334 21376 1 4 57 6 Load > Anticipation
Cingulate Gyrus L 131 8384 −2 −25 37 31 Load > Anticipation
Cuneus R 112 7168 18 −85 28 18 Load > Anticipation
Thalamus R 64 4096 6 −18 4 Load > Anticipation
Declive L 61 3904 −15 −63 −20 Load > Anticipation
Middle Frontal Gyrus L 48 3072 −36 37 28 9 Anticipation > Load
Middle Occipital Gyrus R 43 2752 34 −83 9 19 Load > Anticipation
Anterior Cingulate L 39 2496 −6 31 15 24 Load > Anticipation
Precuneus R 36 2304 5 −43 43 7 Load > Anticipation
Precentral Gyrus R 29 1856 18 −26 64 4 Load > Anticipation
Precentral Gyrus L 24 1536 −18 −29 63 4 Anticipation > Load
MAIN EFFECT OF CUE STIMULUS TYPE
R/L Voxels Volume X Y Z BA Stimulus Effect
Medial Frontal Gyrus R 43 2752 1 44 30 9 Substance > Comparison
Anterior Cingulate L 23 1472 −1 46 8 32 Substance > Comparison
The right amygdala. A significant interaction within the right amygdala (F(2,44) = 7.58, p = 0.001,
partial η2 = 0.256) was examined. Here, groups significantly differed in activation for the anticipation
only condition (F(2, 44) = 4.28, p = 0.02, partial η2 = 0.16) with CAN+ALC-SUD showing significantly
greater activation than CAN+ALC-EXP (M= 0.16, SE= 0.06, p= 0.02). Groups also significantly differed
during the breathing load condition (F(2, 44) = 4.59, p = 0.02, partial η2 = 0.17) with CAN+ALC-SUD
showing lower activation than CAN+ALC-EXP (M = 0.54, SE = 0.18, p = 0.004). CTL did not
significantly differ from either user group during either condition (see Figure 2).
The left inferior frontal gyrus. Within the left IFG (F(2,44) = 5.66, p = 0.006, partial η2 = 0.21),
groups did not differ during anticipation (p = 0.28) but did during the breathing load (F(2,44) = 4.62, p
= 0.015, partial η2 = 0.17). CAN+ALC-SUD exhibited lower activation than both CAN+ALC-EXP (M =
0.27, SE = 0.11, p = 0.049) and CTL (M = 0.27, SE = 0.11, p = 0.049), who did not differ from one another
(see Figure 2).
The right posterior cingulate. An interaction within the right posterior cingulate (F(2,44) = 4.11,
p = 0.02, partial η2 = 0.16) was driven by a significant effect of condition for CTL only (F(1,17) = 11.22,
p = 0.004, partial η2 = 0.39) with greater deactivation while experiencing the breathing load; no simple
main effect for group was seen in this region.
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Figure 2. Neuroimaging ts from the group by interoception condition interaction in (a) the
right amygd la; (b) the left inferior frontal gyrus; (c) the right posterior cingulate; and (d) the left
parahippocampal gyrus. * indicates significant differences.
The left parahippocampal gyrus. ithin the left parahippocampal gyrus (F(2,44) = 6.14, p = 0.004,
partial η2 = 0.22), groups significantly differed during the anticipation condition (F(2,44) = 3.98, p = 0.02,
partial η2 = 0.15) and during the breathing load trials (F(2,44) = 4.23, p = 0.02, partial η2 = 0.16).
Specifically, during anticipation only trials, CTL exhibited significantly greater activation than
CAN+ALC-EXP (M = 0.12, SE = 0.05, p = 0.03), and CAN+ALC-SUD did not differ from either
group. For the breathing load, CAN+ALC-SUD showed significantly lower activation than both CTL
(M = 0.35, SE = 0.15, p = 0.05) and CAN+ALC-EXP (M = 0.40, SE = 0.15, p = 0.03; see Figure 2).
3.2.2. Follow-Up Correlations
Follow-up correlations were conducted within CAN+ALC-SUD and CAN+ALC-EXP between
activation in significant regions and lifetime episodes of cannabis and alcohol use. Within the left IFG,
activation during the breathing load condition negatively correlated with lifetime episodes of alcohol
use (r = −0.546, p = 0.002, R2 = 0.298). Within CAN+ALC-SUD and CAN+ALC-EXP, PHG activation
during the breathing load condition negatively correlated with lifetime episodes of cannabis (r = −0.570,
p = 0.001, R2 = 0.325) and alcohol use (r = −0.473, p = 0.009, R2 = 0.224; see Figure 3).
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4. Discussion
The present investigation aimed to examine the role of negative reinforcement in adolescent
substance use by pairing a cue reactivity paradigm with an aversive interoceptive probe. It was
hypothesized that viewing rewarding substance images would dampen the exaggerated interoceptive
response to an aversive probe that has previously been observed in adolescent substance users [27].
Specifically, CAN+ALC-SUD compared to CTL was hypothesized to show: (1) heightened neural
activation during the breathing load experience in brain regions involved in interoceptive processing
and emotion regulation; (2) heightened neural reward responsivity to substance images; and (3) a
decreased interoceptive neural response to the breathing load when paired with substance images.
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It was also hypothesized that, overall, CAN+ALC-EXP would demonstrate a neural response more
similar to CTL than CAN+ALC-SUD.
The hypotheses were partially supported. In relation to hypothesis one, a consistent pattern
was observed within the left IFG and the left parahippocampal gyrus, wherein CAN+ALC-SUD
exhibited a differential BOLD response to the breathing load compared to CAN+ALC-EXP and
CTL (Figure 3; Table 3). Based on previous work demonstrating that adolescent SUD showed an
increased response to the breathing load [27], it was hypothesized that CAN+ALC-SUD in the present
investigation would also exhibit an increased BOLD response. However, compared to CAN+ALC-EXP
and CTL, CAN+ALC-SUD showed greater deactivation during the breathing load. Although this
result is inconsistent with previous findings among adolescent substance users [27], it is consistent with
previous findings among young adults transitioning from recreational to problematic substance use [39].
A similar pattern was observed in the right amygdala, with CAN+ALC-SUD demonstrating greater
deactivation than CAN+ALC-EXP. However, CTL did not differ from either group. Hypothesis two
was not supported, as CAN+ALC-SUD did not show a differential reward response to substance images
compared to CTL. In line with the lack of an exaggerated reward response to the substance images
within CAN+ALC-SUD, viewing these cues did not attenuate the exaggerated interoceptive response
exhibited by CAN+ALC-SUD (hypothesis 3). Lastly, it was hypothesized that CAN+ALC-EXP would
demonstrate brain responses more similar to CTL than CAN+ALC-SUD; this was partially supported.
During the anticipation only condition, CAN+ALC-EXP showed an inconsistent pattern. However,
during the breathing load condition, CAN+ALC-EXP did not differ from CTL in the right amygdala,
the left IFG, or the left parahippocampal gyrus.
The overall findings suggest that CAN+ALC-SUD experience the aversive breathing load
differently than CTL and CAN+ALC-EXP in brain regions implicated in interoception and emotion
regulation. However, this observation is in the opposite direction of previous findings. Adolescent SUD
has previously shown exaggerated activation rather than deactivation in interoceptive regions when
experiencing an aversive breathing load [27]. Additionally, viewing images of alcohol and cannabis did
not appear to dampen the blunted interoceptive response seen among CAN+ALC-SUD. This finding
would suggest that substance use may not be negatively reinforced by dampening uncomfortable
sensations. The pattern of use demonstrated by adolescent substance users (non-treatment-seeking
users meeting diagnostic criteria) may not be substantial enough to invoke withdrawal-related
symptoms compared to adults who have used heavily for years and/or treatment seekers. Therefore,
using in order to relieve uncomfortable sensations may be less common among adolescent users or
individuals with less significant use patterns. Future studies should collect subjective ratings of how
‘unpleasant’ and ‘aversive’ participants found the breathing load to be while viewing substance and
neutral images separately, as this would provide a clearer understanding of whether or not viewing
substance images can contribute to an overall reduction in the aversiveness of the breathing load.
Lastly, adolescents with SUD showed amygdala deactivation while experiencing the breathing load
but increased activation when anticipating the upcoming load. Previous research has demonstrated
that cannabis users exhibit deactivation in the amygdala while viewing emotional images, indicative
of altered emotion regulation. This may suggest that the observed group differences in the present
study are due to differences in emotion regulation. Although, emotion regulation was not directly
assessed in this study, this is a potential avenue for future research.
Interestingly, there were also no significant findings within the insular cortex despite its central
role in interoception. This contradicts previous research demonstrating that adolescents meeting
criteria for SUD exhibit an increased insular response to the breathing load [27]. It is possible that this
lack of insular cortex findings is due to the more stringent thresholding methods employed in the
present investigation based on current methodological recommendations for the analysis of fMRI data,
as insular activation was present at lower thresholds [51]. Overall, this could suggest that experiencing
the breathing load within the context of an experimental manipulation may not be significant enough
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to elicit a strong insular response among adolescents. Future research should examine whether there is
an age-related difference in response to aversive interoceptive perturbations.
The lack of evidence demonstrating any negative reinforcement-related neural response may also
be because CAN+ALC-SUD did not find the images rewarding enough, given that an exaggerated
reward response was not observed. Altered reward responsivity to substance cues is an established
finding among adult substance users [52]. It is possible, given that adolescents with CAN+ALC-SUD
typically have significantly less use history than adults with CAN+ALC-SUD, that adolescent reward
networks have not yet been altered to show an exaggerated response to substance images. This would
suggest that altered reward responsivity is not a predisposition among CAN+ALC-SUD but rather
a consequence of use. However, an exaggerated neural response to alcohol and cannabis images
in limbic regions has been observed among alcohol-using adolescents and young adults [36,37,53].
A possible reason for our discrepant finding could be differences in characteristics defining each sample.
For example, participants in the present study used both alcohol and cannabis. Reward circuitry among
alcohol and cannabis users may differ from individuals who only consume alcohol and/or cannabis
like those in the previously mentioned investigation [36,37]. Future examination of reward circuitry in
single- and multi-substance users with a larger sample could help to elucidate this question.
Clinically, our findings suggest that interventions aiming to improve coping through emotion
regulation may not be the most effective for adolescent substance users given the lack of evidence that
substance use is driven by negative reinforcement. Alternatively, adolescent substance use may be
driven more by positive reinforcement; CAN+ALC-SUD self-reported significantly more motivations
for use related to positive, as opposed to negative, reinforcement than CAN+ALC-EXP (Table 1).
This aligns with the neurobiological imbalance model, which posits that the development of cognitive
control regions is more protracted from childhood to young adulthood, while reward regions follow
a curvilinear path of development, with a peak in reward responsivity during adolescence [1,54].
This heightened reward response during adolescence can be seen in reward-processing brain regions
(i.e., striatum, insula, anterior cingulate cortex) [55–58] when anticipating and receiving various types of
rewards [59,60]. Behaviorally, this imbalance may contribute to an increase in reward-seeking behaviors,
including drug and alcohol experimentation [59] and increased susceptibility to the motivational
properties of these substances. This may suggest that interventions aimed at helping adolescents
learn alternative ways of experiencing reward may be more effective than those aimed at reducing
uncomfortable sensations [61].
Although adolescent substance users report negative reinforcement of substance use, this was not
observed using a functional imaging paradigm. As reported above, groups also did not differ in their
neural responsivity to the substance images, but this finding may be due to a limitation of study design.
The substance images used in the cue reactivity paradigm may not be potent or personally relevant
enough to elicit a sufficient neural response to overcome the undesirable impact of the breathing load
trials [61–63]. In daily life, adolescents may experience uncomfortable interoceptive signals on par
with the breathing load experienced within the scanner while the rewarding effects of actual substance
use may not be comparable to viewing images. Experimentally administering alcohol and drugs in
conjunction with fMRI is an increasingly popular research method that may be more powerful for
detecting neural changes related to negative reinforcement [64,65]. Alternatively, creating personalized
cue reactivity paradigms using substance-related images from adolescents’ social media accounts
may be an alternative method of increasing the valence of the substance cues. Future researchers
investigating negative reinforcement principles within adolescent substance users should consider
these methods to determine whether a more robust substance cue can elicit neural differences.
An additional limitation of the present study may be the categorization of adolescents based on
meeting criteria for CAN+ALC-SUD. The observed correlations between substance use and neural
response suggest that future examinations of adolescent substance users may be improved using a
dimensional, rather than categorical, approach. Although significant differences in BOLD response
to interoceptive stimulation have been observed among adult substance users with and without
Brain Sci. 2020, 10, 214 14 of 17
CAN+ALC-SUD [14,66,67], amount of substance use may be a more differentiating factor than reported
CAN+ALC-SUD criteria in young users with comparatively little substance use experience. The small
sample size of 13 CAN+ALC-SUD, 16 CAN+ALC-EXP, and 18 CTL also limits the conclusions that can
be drawn from the current study and the ability to look at substance-use groups individually (e.g.,
cannabis vs. alcohol) although comorbid cannabis and alcohol use is common among adolescents [68].
Inclusion of more substance-using adolescents in future studies could help better differentiate between
youth who experiment with drugs and alcohol and those who experience more negative consequences
related to their use. Lastly, CAN+ALC-SUD and CAN+ALC-EXP significantly differed in the amount
of time reported since their last cannabis use. Given that cannabis metabolites can remain in the body
for up to three weeks after regular use, it is possible that the differences observed between groups
could be due to residual effects in the CAN+ALC-SUD group. Therefore, it is possible that the reported
findings are more reflective of the effects of current use and that these differences may resolve with
continued abstinence, highlighting another potential avenue for future research.
Despite these limitations, the present study contributes preliminary findings to our overall
understanding of substance use in adolescence. The findings further support the hypothesis that
interoceptive processing may be altered in substance users. Further, the results suggest that adolescents
may not seek substances to reduce negative or uncomfortable sensations, rather use may be driven
more by increased sensation-seeking and reward responsivity in adolescence. Examining positive
reinforcement in adolescent substance use is an important avenue for future research.
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